HAP Trading, LLC - HEPION PHARMACEUTICALS INC ownership

HEPION PHARMACEUTICALS INC's ticker is HEPA and the CUSIP is 426897104. A total of 43 filers reported holding HEPION PHARMACEUTICALS INC in Q3 2021. The put-call ratio across all filers is 0.39 and the average weighting 0.0%.

Quarter-by-quarter ownership
HAP Trading, LLC ownership history of HEPION PHARMACEUTICALS INC
ValueSharesWeighting
Q1 2022$1,000
-80.0%
15,200
-40.6%
0.00%
Q3 2021$5,000
-77.3%
25,600
-36.8%
0.00%
Q2 2021$22,000
+15.8%
40,500
-16.3%
0.00%
-100.0%
Q1 2021$19,000
+72.7%
48,400
+106.0%
0.00%
Q4 2020$11,00023,5000.00%
Other shareholders
HEPION PHARMACEUTICALS INC shareholders Q3 2021
NameSharesValueWeighting ↓
SABBY MANAGEMENT, LLC 306,338$564,0000.11%
PVG ASSET MANAGEMENT CORP 14,140$26,018,0000.08%
GSA CAPITAL PARTNERS LLP 160,775$296,0000.05%
Virtu Financial LLC 179,030$329,0000.02%
Allen Capital Group, LLC 23,685$44,0000.01%
McAdam, LLC 36,641$67,0000.01%
SAN FRANCISCO SENTRY INVESTMENT GROUP (CA) 10,000$18,0000.01%
ZEKE CAPITAL ADVISORS, LLC 50,000$92,0000.01%
JGP Wealth Management, LLC 15,000$28,0000.01%
Onex Canada Asset Management Inc. 40,000$74,0000.00%
View complete list of HEPION PHARMACEUTICALS INC shareholders